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Abstract: Over the years, various techniques have been proposed for the quantitative evaluation
of microbial biofilms. Spectrophotometry after crystal violet staining is a widespread method for
biofilm evaluation, but several data indicate that it does not guarantee a good specificity, although
it is rather easy to use and cost saving. Confocal laser microscopy is one of the most sensitive and
specific tools to study biofilms, and it is largely used for research. However, in some cases, no
quantitative measurement of the matrix thickness or of the amount of embedded microorganisms
has been performed, due to limitation in availability of dedicated software. For this reason, we have
developed a protocol to evaluate the microbial biofilm formed on sandblasted titanium used for
orthopaedic implants, that allows measurement of biomass volume and the amount of included
cells. Results indicate good reproducibility in terms of measurement of biomass and microbial
cells. Moreover, this protocol has proved to be applicable for evaluation of the efficacy of different
anti-biofilm treatments used in the orthopaedic setting. Summing up, the protocol here described is a
valid and inexpensive method for the study of microbial biofilm on prosthetic implant materials.
Keywords: confocal laser scanning microscopy; biofilm; fluorescent stains; images analysis;
prosthetic implants
1. Introduction
In the recent past, it has become evident that knowledge of biofilm composition and architecture is
of crucial importance, due to its role in environment, industrial processes and human diseases. Biofilm
is defined as a microbial community protected by self-produced polymeric matrix and adherent
to various surfaces, such as prosthetic implants used in the clinical setting [1,2]. Biofilm-related
infections are known to be more difficult to eradicate in comparison to infections caused by planktonic
bacteria [3,4]. Indeed, several studies showed an increase of about 1000 times in resistance to certain
antibiotics for bacteria embedded into biofilm matrix, compared to their planktonic counterpart [5].
Over the years, various techniques have been developed in order to highlight and measure the
amount of microbial biofilms produced on different substrates. One of the oldest and most widely
used method is the quantification of biofilm stained with crystal violet by spectrophotometry [6].
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Unfortunately, some reports evidenced the scarce specificity of this semi-quantitative method [7,8],
which, with the advances in technology, has been replaced by more complex technologies able not
only to sharpen the sensitivity, but also to increase the specificity of biofilm evaluation. Analysis
performed by means of confocal laser scanning microscopy (CLSM) is one of the most sensitive and
specific assays to evaluate microbial biofilms, able to guarantee a high quality/price ratio. CLSM
was initially developed for the study of cell cultures and has been adapted for the study of biofilm
since 1995 [9–11]. CLSM significantly enhances the spatial resolution of the sample, eliminating the
halos due to the light diffused from planes that are out of focus. Moreover, CLSM allows one to
focus a laser with high precision on the sample, markedly increasing resolution and depth of the field.
One or more lasers, typically semiconductors, constitute its light source for each excitation frequency
requested. A computer system handles the mechanism directing the light beam. The images are
obtained by synchronizing the excitation beam and the detection device. The different fluorescent
markers can be depicted with different colors, allowing one to appreciate the three-dimensionality
of the sample. Nonetheless, differences between the layer of cells and the visible structure of the
exopolysaccharides matrix (EPS), which represents the major component of biofilm, notably complicate
analysis of biofilm. For this reason, preliminary studies were initially conducted only to display biofilm
without performing any quantitative measurement in relation to the thickness of the matrix and the
number of embedded bacteria. Other studies using genetically engineered bacteria to quantify biofilm,
raised some concerns about the use of strains artificially created in laboratory, which might have no
relation with clinical isolates [12,13]. In recent years, research on the use of CLSM for the analysis
of microbial biofilms has taken many steps forward, developing new dyes and dedicated graphic
software able to quantify the biofilm [14,15]. Commercial kits are now available on the market, favoring
the repeatability of analysis by making sample treatment uniform. The major limitation in the study
of biofilms grown on prosthetic implants is the lack of standardized in vitro models and of easy to
use assays. For this reason, the need to evolve and adapt these techniques to specific purposes, in
the attempt to develop a method easy to perform, even using different prosthetic implants as growth
support, is quite urgent.
The aim of the present study was to develop a CLSM technique that not only allows one to
highlight biofilms, but also measures biomass volume and quantifies living and dead microorganisms
embedded in a biofilm grown on sandblasted titanium.
2. Results
The protocol was validated by the analysis of several images acquired from biofilms formed
on sandblasted titanium discs by Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans.
Biofilms were evaluated by using the FilmTracer™ LIVE/DEAD® Biofilm Viability Kit (Invitrogen Ltd.,
Paisley, UK), which consists of a mixture of the green-fluorescent nucleic acid stain SYTO® 9 and
the red-fluorescent nucleic acid stain propidium iodide (PI). These stains differ in both their spectral
characteristics and ability to penetrate healthy microbial cells. The SYTO® 9 stain generally labels
all microorganisms in a population, either those with intact membranes and those with damaged
membranes. In contrast, PI penetrates only microorganisms with damaged membranes, reducing the
SYTO® 9 fluorescence when both dyes are present. Thus, with an appropriate mixture of the SYTO® 9
and PI stains, microorganisms with intact cell membranes (i.e., live) are stained in fluorescent green,
whereas microorganisms with damaged membranes (i.e., dead) are stained in fluorescent red.
For each image, a specific user-friendly software (Imaris, Bitplane AG, Zurich, Switzerland)
allowed the reconstruction of a 3D image of the portion of the disc. Volume rendering was obtained
by initially selecting only the blue color channel corresponding to titanium and coverslip surfaces,
and configuring them as the lower and the upper sides of the image. Then, the green and red
channels, corresponding respectively to the cell volume of living and dead microorganisms within
the biofilm, were added to the rendering. Finally, the intensity of the blue channel corresponding to
the titanium and coverslip surfaces was adjusted to decrease overlapping with the other channels
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and to better highlight the volume of live and dead cells. As shown in Figures 1 and 2 the
elaboration of the acquired images provide visualization of the disc’s surface, biofilm matrix and
biofilm-embedded microorganisms.
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formed on sandblasted titanium disc; (B) S. aureus biofilm treated with an anti-biofilm substance;  
(C) P. aeruginosa biofilm formed on sandblasted titanium disc; (D) P. aeruginosa biofilm treated with 
an anti-biofilm substance; (E) C. albicans biofilm formed on sandblasted titanium disc; (F) C. albicans 
biofilm treated with an anti-biofilm substance. 
 
Figure 2. 3D image of P. aeruginosa biofilm using SYTO® 9 alone. 3D reconstruction of P. aeruginosa 
untreated and treated biofilm by confocal laser scanning microscopy (CLSM). Biofilm were grown for 
72 h and then stained with SYTO® 9. (A) P. aeruginosa biofilm formed on sandblasted titanium disc; 
(B) P. aeruginosa biofilm treated with an anti-biofilm substance. 
2.1. Quantification of Total Biomass Volume 
Quantification of total biomass volume was performed by calculating the mean value of biofilm 
thickness multiplied for the total surface of the acquired portions through the software Leica LAS AF 
(Leica Microsystems CMS GmbH, Mannheim, Germany). Table 1 reports the measurements of  
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Figure 1. 3D image of S. aureus, P. aeruginosa and C. albicans biofilms using SYTO® 9 and propidium
iodide (PI). 3D reconstruction of S. aureus, P. aeruginosa and C. albicans untreated and treated biofilms
by CLSM. Biofilms were grown for 72 h and then stained with SYTO® 9 and PI. (A) S. aureus biofilm
formed on sandblasted titanium disc; (B) S. aureus biofilm treated with an anti-biofilm substance;
(C) P. aeruginosa biofilm formed on sandblasted titanium disc; (D) P. aeruginosa biofilm treated with
an anti-biofilm substance; (E) C. albicans biofilm formed on sandblasted titanium disc; (F) C. albicans
biofilm treated with an anti-biofilm substance.
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Figure 2. 3D image of P. aeruginosa biofi m using SYTO® 9 alone. 3D reconstruction of P. aeruginosa
untreated and treat biofilm by confocal laser sca ning microscopy (CLSM). Biofilm were grown for
72 h and then tained with SYTO® 9. (A) P. aerugino a iofilm formed on sandblasted titanium disc;
(B) P. aeruginosa biofilm treated with an anti-biofilm substance.
To better evaluate the applicability of our method for the assessment of the activity of anti-biofilm
treatments, we determined the efficacy of three different compounds in reducing biofilm, one for each
microbial strain. All the analyses of the biofilms were easily reproducible.
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2.1. Quantification of Total Biomass Volume
Quantification of total biomass volume was performed by calculating the mean value of biofilm
thickness multiplied for the total surface of the acquired portions through the software Leica LAS
AF (Leica Microsystems CMS GmbH, Mannheim, Germany). Table 1 reports the measurements of
S. aureus, P. aeruginosa and C. albicans biomass volumes conducted on different control and treated discs.
Results are expressed as mean ˘ SD of data obtained from three different titanium discs. For each disc,
at least four microscopic fields were analyzed and means calculated.
Table 1. Mean and standard deviation (SD) values of Biomass Volume (BV), Coefficient of Variation
(%) of controls (untreated samples) and samples treated with anti-biofilm substance.
Microorganism BV (µm3) ˘ SD (Controls) CV%(Controls)
BV (µm3) ˘ SD
(Anti-Biofilm Treatment)
CV%
(Anti-Biofilm
Treatment)
p-Value
(Treated vs.
Controls)
S. aureus 6.52 ˆ 106 ˘ 1.81 ˆ 105 2.78% 4.64 ˆ 106 ˘ 2.23 ˆ 105 4.81% 0.00001
P. aeruginosa 1.54 ˆ 107 ˘ 5.19 ˆ 105 3.37% 8.98 ˆ 106 ˘ 3.55 ˆ 105 3.95% 0.000001
C. albicans 5.23 ˆ 106 ˘ 9.88 ˆ 104 1.89% 3.74 ˆ 106 ˘ 1.37 ˆ 105 3.66% 0.000005
As shown, measurement of biofilm volume was quite reproducible for all microorganisms.
As reported in Table 1, also the determination of biomass after anti-biofilm treatments, which caused
a sustained reduction of microbial mass, produced repeatable results with CV% ranging from 1.89%
to 4.81% (mean CV%: 3.41%). Treatments caused a significant reduction of Biomass volume (BV) in
respect to control samples (p < 0.001).
2.2. Quantification of Volume Occupied by Microbial Cells into Biofilm
The FilmTracer™ LIVE/DEAD® staining properties, together with the instrumental set-up
allowed quantification of the volume occupied by all of the cells embedded in the matrix. In particular,
using SYTO® 9 stain alone, it was possible to stain all microbial cells (live and dead) and consequently
to quantify the volume occupied by all the cells into the matrix (Figure 3). Furthermore, using SYTO®
9 and PI together, the ratio between live and dead cells was calculated, thus simultaneously evaluating
anti-biofilm and antimicrobial activity of any compound (Figure 4).
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Figure 3. P. aeruginosa biofilm composition of untreated (control) and treated sample obtained using
SYTO 9® alone. Pie charts represent the P. aeruginosa biomass components proportion obtained from
CLSM images analysis performed by iji s ft are (Fiji, ImageJ, Wayne Rasband National Institutes of
Health, Beth , D, USA). Blue: biofilm matrix; g een: total cells within the biofilm. For the treated
sample, the loss f bi film caused by treatment with an anti-biofilm substance in comparison with
control is reported in gray.
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substance in comparison with control is reported in gray.
3. Discussion
A great challenge of the 21st century is the development of novel and effective strategies for the
treatment of infections sustained by microbial biofilms.
In this paper, we presented a protocol for in vitro evaluation of biofilm grown on sandblasted
titanium used for prosthetic implants. This method has been developed to respond to the need for a
highly specific and sensitive procedure for investigating the activity of anti-biofilm agents at a low
cost, and to evaluate biofilms in diagnosis of biofilm-related infections. Since the ability to growth
in biofilm may differ depending on the substrate, it is necessary to implement classical methods for
the study of biofilms, introducing those materials that are commonly used in prosthetic orthopaedic
surgery, and to use microbial strains clinically isolated from prosthetic infections without introducing
any genetic manipulation.
For many years, the anti-biofilm activity was investigated by semi-quantitative methods. In 1980s,
Christensen et al. [6] developed the first semi-quantitative method for biofilm evaluation, measuring
the absorbance of crystal violet dye included into the biofilm. This method is still widely used [16–18],
thanks to the ease of the procedure and the low costs, although, by time, experience pointed out its
low sensitivity and specificity, due to the fact that crystal violet is a basic dye that readily binds to
negatively charged molecules (and thus to acidic polysaccharides in the extracellular matrix) and the
wide variability of results due to the variable extraction of the dye by ethanol. [19]. Moreover, this assay
is performed on air-dried biofilm and it is unable to yield any information on biofilm three-dimensional
architecture. On the contrary, with the aid of CLSM, biofilms can be studied in their natural hydrated
state, with no requirement for desiccation nor other invasive and destructive processing methods such
as chemical fixation or embedding techniques.
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Indirect methods are simple and fast for biofilm analysis, and one of them, the count of microbial
cells embedded in biofilm, is one of the most commonly used technique [20]. However, this kind of
analysis presents some limitations and lack of precision, as microorganisms are detached with physical
or chemical treatments that may destroy the biomass, thus altering vital microbial counts. Sonication,
for instance, is widely used to detach and recover bacteria embedded in biofilm, but it is known that
this treatment is not very effective towards Staphylococcus epidermidis biofilm [21].
For these reasons, with improvements in technology, semi quantitative methods have been
replaced by more complex procedures, using instrumentation able to increase sensitivity and specificity.
Initially, the use of scanning electron microscopy (SEM) seemed to solve many of the problems
presented by the older methods, in that it provided excellent images of biofilm, with high resolution
power and magnification [22,23]. However, the lack of ability to perform quantification, the high cost
of instrumentation, the long time needed for sample preparation and the need for skilled personnel
have greatly restricted its use.
CLSM analysis is undoubtedly one of the most sensitive and specific techniques for visualization
and analysis of biofilm structure. CLSM is characterized by high sensitivity and specificity and allows
3D digital recreation of image of whole portions of biofilm with high resolution. However, some
problems in this CLSM application have been identified, especially due to the particular structure of
the biofilm that makes its analysis unwieldy and difficult to perform.
Our method has the purpose of facilitating these analyses, still providing good results with simple
procedures. In the last two decades, graphics dedicated software or particular biofilm treatments have
also been developed to deeply analyze biofilms [14,15,24].
In order to facilitate the graphics processing of acquired sections, we opted for the use of a
user-friendly software (Imaris, Bitplane AG).
From the technical point of view and in terms of processing algorithms, Fiji software (Fiji, ImageJ,
Wayne Rasband National Institutes of Health) does not present substantial differences if compared to
other software developed for the study of biofilm (i.e., COMSTAT) and, as previously mentioned, its use
is simple and intuitive. Moreover, it is a freely available software, thus not requiring license costs.
Recently, Khajotia et al. [9] have developed an interesting approach to biofilm evaluation, allowing
quantification of the three main components of Streptococcus mutans biofilm: EPS, nucleic acids (cells)
and proteins.
Differently from the method described by Khajotia et al. [9], the use of a high acquisition frequency
(700 Hz) in simultaneous acquisition mode allowed us to avoid false co-localization of fluorescence
due to microbial movement. Moreover, the use of a third channel used in reflection mode, allows
the distinction of the support from the biofilms mass, and enable observation of the interior of the
materials ridges (such as sandblasted titanium). To our knowledge, this is the first method that
allows the simultaneous visualization of biofilms and of the substrate used as support for biofilm
formation (e.g., titanium). In fact, usually, micrographs represent two- or three-dimensional projections
of biofilms without displaying the underlying supporting materials. This is crucial for prosthetic
joint and other device-related infections, where the study of interactions between implant surface and
bacteria is of outstanding importance.
The fluorescent staining used for this protocol was the FilmTracer™ LIVE/DEAD® Biofilm
Viability kit, a simple and reliable staining for both gram-positive and negative bacteria, and fungi like
C. albicans, which has been successfully used to stain biofilm by several authors [25–29].
Results obtained in this study show that our technique can be used for a thorough analysis of
the microbial biofilms developed on prosthetic implants. Here we have presented two modalities to
quantify the volume occupied by microbial cells embedded in the biofilm. Quantification of all cells
(both live and dead) represents an easy way to analyze biofilm. However, the use of the two fluorescent
dyes provides a complete and thorough analysis of biofilm, although, in some cases, differences in
biofilm biochemical composition may hamper determination of the amount of PI bound to dead cells.
Int. J. Mol. Sci. 2016, 17, 293 7 of 10
Regardless, even when only total cell volumes were measured, a decrease in cell volume in samples
treated with anti-biofilm substances was observed.
Since biofilms have an irregular structure made of canyons and peaks, we recommend obtaining
at least four acquisition for each sample to ensure highly precise and reliable data. Thanks to its ease
of use and its good adaptability, this protocol can be routinely applied, for example, to evaluate the
effect of substances on biofilm grown on different prosthetic implants used in clinical practice.
4. Materials and Methods
4.1. Microbial Strains
The protocol was set up by using one strain of methicillin-resistant S. aureus and one strain
of P. aeruginosa, isolated from two patients undergoing septic revision surgery of the knee and hip
prostheses, respectively, and one strain of C. albicans, isolated from a patient with wound drainage
after hip replacement. Surgery was performed at the Center for Reconstructive Surgery of Bone
and Osteoarticular Infections of Galeazzi Orthopaedic Institute (Milan, Italy). Microorganisms were
identified at Laboratory of Clinical Chemistry and Microbiology of the same Institute. Microbial
identification was performed by means of biochemical assays (Vitek 2; Biomerieux, Marcy l’Etoile,
France) and, only for bacterial strains, further confirmed by DNA sequencing of about 80 bp of
variable regions V1 and V3 of the 16S rRNA gene by Pyrosequencing (PSQ96RA, Diatech, Jesi, Italy),
as previously described [15,16].
4.2. Screening for Biofilm Production
Screening for biofilm production was conducted on 96-wells polystyrene microtiter plates
according to Christensen et al. [6]. For each sample, 20 µL of an overnight microbial suspension
were added to 180 µL of Tryptic Soy Broth (TSB) in at least 3 wells of the microtiter plate. Overnight
incubation was carried out aerobically at 37 ˝C, then medium was refreshed in order to remove not
adherent microorganisms, and plates were further incubated for 72 h at 37 ˝C. Negative controls,
comprising wells containing 200 µL of TSB without microbial suspension, were also prepared under
the same conditions. At the end of the incubation period, medium was removed, and three washes
with Phosphate Buffered Saline (PBS) were performed in order to remove microorganisms not included
into biofilm. After air-drying, each well was stained with 200 µL of 3% crystal violet solution for 10
min, then the excess of dye was removed with three washes with PBS. Once dried, 200 µL of absolute
ethanol were added to each well, in order to solubilize the dye attached to biofilm. The amount of
biofilm produced was determined by spectrophotometric reading at a wavelength of 595 nm using a
microplate reader (Multiskan FC, Thermo Scientific; Milan, Italy). Strains were classified as strong
producers of biofilm by comparing their optical density with that of the negative control [6].
4.3. Biofilm Formation on Prosthetic Material
Sandblasted titanium discs (20 mm diameter ˆ 6 mm thickness; Adler Ortho BATCH J04051)
were used as substrates for biofilm formation. Discs were placed into a 6-well plate, with each well
containing 4.8 mL of TSB and inoculated with 200 µL of a 0.5 McFarland turbidity microbial suspension.
Plates were incubated at 37 ˝C for 72 h on an orbital shaker, in order to obtain a visible biofilm mass.
Before staining, not adherent microorganisms were removed by three washings with sterile saline.
4.4. Fluorescent Staining
Staining with FilmTracer™ LIVE/DEAD® Biofilm viability kit (Molecular Probes, Life
Technologies Ltd.) was performed according to the instructions provided by the manufacturer. Briefly,
a working solution of fluorescent stains was prepared by adding 3 µL of SYTO® 9 stain and 3 µL of
PI stain to 1 mL of filter-sterilized water. Two hundreds µL of staining solution were deposited on
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disc surface and, after 15 min incubation at room temperature in the dark, samples were washed with
sterile saline for removing the excess dyes and rinsed with water from the base of the support material.
4.5. CLSM Analysis
Stained biofilms were examined with a confocal laser microscope (Leica model TCS SP5;
Leica Microsystems CMS GmbH, Mannheim, Germany) using a 20ˆ dry objective (HC PL FLUOTAR
20.0 ˆ 0.50 DRY) plus a 2ˆ electronic zoom. In order to minimize the air contact and maintain constant
sample moisture condition, a coverslip was used on the specimen.
A 488 nm laser line was used to excite SYTO® 9, while the fluorescent emission was detected from
500 to 540 nm. PI was excited with 561 nm laser line and its fluorescent emission was detected from
600 to 695 nm. In order to avoid false co-localization of fluorescence due to microbial movement, we
opted for a simultaneous acquisition mode of the two channels, in which the laser beam scanned the
visual field at a frequency of 700 Hz. Moreover, using a third laser line (633 nm) in reflection mode,
it was possible to determine with high accuracy both titanium disc (starting acquisition point) and
coverslip (ending acquisition point) reflecting surfaces. Images from at least four randomly selected
areas were acquired for each disk. For each of them, sequential optical sections of 2 µm were collected
along the z axis over the complete thickness of the sample to be subsequently analyzed, quantified by
Fiji software (Fiji, ImageJ, Wayne Rasband National Institutes of Health) and rendered into 3D mode
by Imaris software (Imaris, Bitplane AG).
4.6. CLSM Quantification
The images acquired during the experimental session were processed through a segmentation
algorithm (Fiji, ImageJ, Wayne Rasband National Institutes of Health) capable of separating the signals
between the background and the sample, in order to obtain a proportionality between the number
of microorganisms and the fluorescent signal. More precisely, the algorithm measured the volume
occupied by the fluorescent signal recorded in each pixel with value exceeding a threshold on the scale
of gray tones that was established to distinguish a specific signal from the background noise. Above
this classification, a dimension filter was subsequently applied, using a variable size depending on
the type of microorganism used. This filter size represented the approximate value of the volume of
the microbial species used for measurements. A variation (%) on the threshold value calculated by
Fiji software was applied to better reflect the distinction of microorganisms from background. The
software calculated the volume occupied by live microorganisms, by measuring the volume occupied
by the relevant fluorescence. The measurement of the volume of the scanned sample was performed
by manual calculation of the mean value of biofilm thickness multiplied for total surface of portions
acquired through the software Leica LAS AF.
4.7. Statistical Analysis
Results of biomass volume obtained by CLSM images analysis are presented as mean ˘ SD.
Repeatability of data is expressed as coefficient of variation (CV%). A p-value equal or less than 0.05
was considered as statistically significant.
5. Conclusions
Summing up, the protocol here described is a valid and inexpensive method for the study of
microbial biofilm on prosthetic implant materials.
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